Schirmbeck, Frederike http://orcid.org/0000-0003-1700-0958
,
Konijn, Max
Hoetjes, Vera
Zink, Mathias
de Haan, Lieuwe
Funding for this research was provided by:
Deutscher Akademischer Austauschdienst
ZonMw (10-000-1002)
Article History
Received: 24 October 2017
Accepted: 24 February 2018
First Online: 8 March 2018
Compliance with ethical standards
:
: All authors declare no conflict of interest regarding the present study. F. Schirmbeck was supported by a fellowship within the Postdoc Program of the German Academic Exchange Service (DAAD). M. Zink has received unrestricted scientific grants of the German Research Foundation (DFG), Servier and Trommsdorff and has further received speaker and travel support from Pfizer Pharma GmbH, Bristol-Myers Squibb, Otsuka, Lundbeck, Astra Zeneca, Eli-Lilly, Janssen-Cilag, Roche, Ferrer and Trommsdorff. L. de Haan has received speakers-bureau honoraria from Eli Lilly, Janssen-Cilag Pharmaceuticals and AstraZeneca BV and an investigator initiated unrestricted research grant from Eli Lilly.
: Al participants provided written informed consent prior to their inclusion in the current study. The study was approved by the accredited Medical Ethics Review Committee (METC) and has, therefore, been performed in accordance with the ethical standards laid down in the Declaration of Helsinki.